Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.9000 (-3.42%) ($7.3900 - $8.6000) on Tue. May. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 33.95% (three month average) | RSI | 91 | Latest Price | $7.9000(-3.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 49.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IVE(27%) XOP(34%) OIH(33%) DIA(29%) XLE(29%) | Factors Impacting CAPR price | CAPR will decline at least -16.975% in a week (0% probabilities). VIXM(-25%) VXX(-23%) TLT(-19%) UUP(-16%) BND(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -16.975% (StdDev 33.95%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
5 Day Moving Average | $7.4(6.76%) | 10 Day Moving Average | $7.39(6.9%) | 20 Day Moving Average | $4.81(64.24%) | To recent high | -7.1% | To recent low | 16.2% | Market Cap | $156m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |